Abstract
Acne vulgaris (AV) is a common skin condition that can cause substantial psychosocial impact. Treatments of AV target clearing and prevention of lesions and reducing scarring and dyspigmentation. Numerous medications are used to target one or more of the pathogenetic factors contributing to AV. The irritative potential of acne products and their tolerability are important aspects that may affect patient adherence to therapies. Adjunctive skincare products offer several benefits to acne-prone skin, by reducing redness, inflammation, and discomfort and improving skin texture. In addition, complementing AV prescription interventions reduces the time to healing of lesions, the extent of scarring, and the number and severity of breakouts. This multicentre, open-label, single-cohort study evaluated the use of ceramide-containing hydrating cream-to-foam cleanser and facial moisturizing lotion for improving topical treatment tolerability and adherence in facial acne. Combining a proper skincare regimen with acne treatments may help decrease their irritating potential and support the skin barrier, which can improve treatment adherence and ultimately, treatment outcomes.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
